+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 19Years +
All Genders
ID05244408

Evaluation of Blood Biomarkers to Classify Injury Severity and Predict Neurologic Recovery in Acute Traumatic Spinal Cord Injury Patients

Led by University of British Columbia · Updated on 2026-09-23

120

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating blood biomarkers to classify injury severity and predict neurologic recovery in patients with acute traumatic spinal cord injuries SCI. This observational study at Vancouver General Hospital focuses on patients with cervical and thoracic SCI and aims to validate specific proteins in the blood, understand their serum and plasma relationships, and establish the accuracy of point-of-care devices for these biomarkers. The study also supports the collection of biospecimens for the International Spinal Cord Injury Biobank. Participants include those with traumatic spinal cord injuries and patients with spinal fractures or dislocations without neurologic injury as controls. Blood samples are collected daily for the first week after injury, with follow-up neurologic assessments conducted at 6 and 12 months. The study measures blood levels of Neurofilament Light Chain NF-L and Glial Fibrillary Acidic Protein GFAP, and assesses neurologic function using standard examinations. During the study, participants provide informed consent and have blood drawn through existing arterial, central, or intravenous lines within 24 hours of injury. Researchers monitor biochemical markers in blood during the first week and conduct neurologic evaluations at 6 and 12 months post-injury. The study duration extends until December 2030, with ongoing data collection and biospecimen support to improve understanding of SCI recovery and biomarker accuracy.

CONDITIONS

Brief Title

"SCRIBBLE" Spinal Cord Injury Blood Biomarker Longitudinal Evaluation

Research Team

A

Allan Aludino

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here